Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1974 1
2006 1
2008 1
2011 1
2012 5
2013 1
2014 4
2015 3
2016 1
2017 2
2018 1
2020 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

21 results
Results by year
Filters applied: . Clear all
Page 1
Cancer stem cells.
Yu Z, Pestell TG, Lisanti MP, Pestell RG. Yu Z, et al. Among authors: pestell tg. Int J Biochem Cell Biol. 2012 Dec;44(12):2144-51. doi: 10.1016/j.biocel.2012.08.022. Epub 2012 Sep 2. Int J Biochem Cell Biol. 2012. PMID: 22981632 Free PMC article. Review.
The membrane-associated form of cyclin D1 enhances cellular invasion.
Chen K, Jiao X, Ashton A, Di Rocco A, Pestell TG, Sun Y, Zhao J, Casimiro MC, Li Z, Lisanti MP, McCue PA, Shen D, Achilefu S, Rui H, Pestell RG. Chen K, et al. Among authors: pestell tg. Oncogenesis. 2020 Sep 18;9(9):83. doi: 10.1038/s41389-020-00266-y. Oncogenesis. 2020. PMID: 32948740 Free PMC article.
MicroRNAs and cancer stem cells: the sword and the shield.
Sun X, Jiao X, Pestell TG, Fan C, Qin S, Mirabelli E, Ren H, Pestell RG. Sun X, et al. Among authors: pestell tg. Oncogene. 2014 Oct 16;33(42):4967-77. doi: 10.1038/onc.2013.492. Epub 2013 Nov 18. Oncogene. 2014. PMID: 24240682 Review.
Cyclin D1-mediated microRNA expression signature predicts breast cancer outcome.
Wang G, Gormley M, Qiao J, Zhao Q, Wang M, Di Sante G, Deng S, Dong L, Pestell T, Ju X, Casimiro MC, Addya S, Ertel A, Tozeren A, Li Q, Yu Z, Pestell RG. Wang G, et al. Among authors: pestell t. Theranostics. 2018 Mar 11;8(8):2251-2263. doi: 10.7150/thno.23877. eCollection 2018. Theranostics. 2018. PMID: 29721077 Free PMC article.
Cyclin D1 Restrains Oncogene-Induced Autophagy by Regulating the AMPK-LKB1 Signaling Axis.
Casimiro MC, Di Sante G, Di Rocco A, Loro E, Pupo C, Pestell TG, Bisetto S, Velasco-Velázquez MA, Jiao X, Li Z, Kusminski CM, Seifert EL, Wang C, Ly D, Zheng B, Shen CH, Scherer PE, Pestell RG. Casimiro MC, et al. Among authors: pestell tg. Cancer Res. 2017 Jul 1;77(13):3391-3405. doi: 10.1158/0008-5472.CAN-16-0425. Epub 2017 May 18. Cancer Res. 2017. PMID: 28522753 Free PMC article.
Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth.
Pestell TG, Jiao X, Kumar M, Peck AR, Prisco M, Deng S, Li Z, Ertel A, Casimiro MC, Ju X, Di Rocco A, Di Sante G, Katiyar S, Shupp A, Lisanti MP, Jain P, Wu K, Rui H, Hooper DC, Yu Z, Goldman AR, Speicher DW, Laury-Kleintop L, Pestell RG. Pestell TG, et al. Oncotarget. 2017 Aug 4;8(47):81754-81775. doi: 10.18632/oncotarget.19953. eCollection 2017 Oct 10. Oncotarget. 2017. PMID: 29137220 Free PMC article.
CCR5 antagonist blocks metastasis of basal breast cancer cells.
Velasco-Velázquez M, Jiao X, De La Fuente M, Pestell TG, Ertel A, Lisanti MP, Pestell RG. Velasco-Velázquez M, et al. Among authors: pestell tg. Cancer Res. 2012 Aug 1;72(15):3839-50. doi: 10.1158/0008-5472.CAN-11-3917. Epub 2012 May 25. Cancer Res. 2012. PMID: 22637726 Free article.
CAPER, a novel regulator of human breast cancer progression.
Mercier I, Gonzales DM, Quann K, Pestell TG, Molchansky A, Sotgia F, Hulit J, Gandara R, Wang C, Pestell RG, Lisanti MP, Jasmin JF. Mercier I, et al. Among authors: pestell tg. Cell Cycle. 2014;13(8):1256-64. doi: 10.4161/cc.28156. Epub 2014 Feb 17. Cell Cycle. 2014. PMID: 24621503 Free PMC article.
21 results